These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 28373528)

  • 21. Cardiac amyloidosis.
    Maredia N; Ray SG
    Clin Med (Lond); 2005; 5(5):504-9. PubMed ID: 16268336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac amyloidosis: approaches to diagnosis and management.
    Desai HV; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(1):1-11. PubMed ID: 20010333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
    Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
    Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
    Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
    Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiac amyloidosis: How to recognize them and manage them?].
    Bodez D; Galat A; Guellich A; Deux JF; Rosso J; Le Bras F; Funalot B; Fanen P; Benhaiem N; Planté-Bordeneuve V; Dubois-Randé JL; Lellouche N; Guendouz S; Molinier-Frenkel V; Mohty D; Damy T
    Presse Med; 2016 Oct; 45(10):845-855. PubMed ID: 27492996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist.
    Perfetto F; Zampieri M; Fumagalli C; Allinovi M; Cappelli F
    Intern Emerg Med; 2022 Jun; 17(4):957-969. PubMed ID: 35325395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloidosis as a Systemic Disease in Context.
    Cuddy SAM; Falk RH
    Can J Cardiol; 2020 Mar; 36(3):396-407. PubMed ID: 32145867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Amyloidosis.
    Bloom MW; Gorevic PD
    Ann Intern Med; 2023 Mar; 176(3):ITC33-ITC48. PubMed ID: 36913688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac amyloidosis: a case series of 14 patients, description and prognosis].
    Isabel C; Georgin-Lavialle S; Aouba A; Delarue R; Nochy D; Karras A; Azarine A; Hermine O; Ranque B; Hagège A; Pouchot J
    Rev Med Interne; 2013 Nov; 34(11):671-8. PubMed ID: 24090573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac transthyretin amyloidosis.
    Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
    Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
    Yamamoto H; Yokochi T
    ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthyretin cardiac amyloidosis.
    Porcari A; Fontana M; Gillmore JD
    Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiac amyloidosis].
    Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
    Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel strategies for the diagnosis and treatment of cardiac amyloidosis.
    Palladini G; Milani P; Merlini G
    Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1195-211. PubMed ID: 26496239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.
    Perlini S; Mussinelli R; Salinaro F
    Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy.
    Fontana M; Porcari A; Hawkins PN
    Glob Heart; 2023; 18(1):63. PubMed ID: 38028963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.